Novavax and CPL Biologicals Influenza Vaccine Manufacturing Facility, India


Pandemic influenza strains such as H1N1 swine flu require the use of VLP technology to produce a large amount of vaccine in a short time.



| 1 | 2 | 3 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter Sign-Up
Advertise With Us
About Us
Client Area


RSS What is RSS
The website for the pharmaceutical industry